0001562180-21-002077.txt : 20210308 0001562180-21-002077.hdr.sgml : 20210308 20210308174454 ACCESSION NUMBER: 0001562180-21-002077 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210304 FILED AS OF DATE: 20210308 DATE AS OF CHANGE: 20210308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDSMITH MARK A CENTRAL INDEX KEY: 0001246842 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38584 FILM NUMBER: 21723227 MAIL ADDRESS: STREET 1: 925 PAGE MILL ROAD CITY: PALO ALTO STATE: CA ZIP: 94304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CONSTELLATION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001434418 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-714-0555 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2021-03-04 false 0001434418 CONSTELLATION PHARMACEUTICALS INC CNST 0001246842 GOLDSMITH MARK A C/O CONSTELLATION PHARMACEUTICALS, INC. 215 FIRST STREET, SUITE 200 CAMBRIDGE MA 02142 true false false false Common Stock 2021-03-04 4 M false 14987.00 0.00 A 14987.00 D Common Stock 74870.00 I Owned by Trusts for which Mark A. Goldsmith is a Trustee Stock Option (right to buy) 1.55 2021-03-04 4 M false 14987.00 0.00 D 2021-03-10 Common Stock 14987.00 0.00 D Shares are fully vested. /s/ Emma Reeve, as Attorney-in-Fact for Mark A. Goldsmith 2021-03-08